Authors: VALERIUS T ELSASSER D REPP R VANDEWINKEL JGJ GRAMATZKI M GLENNIE M

Citation: T. Valerius et al., HLA CLASS-II ANTIBODIES RECRUIT G-CSF ACTIVATED NEUTROPHILS FOR TREATMENT OF B-CELL MALIGNANCIES, Leukemia & lymphoma, 26(3-4), 1997, pp. 261

Authors: VALERIUS T WURFLEIN D ELSASSER D STOCKMEYER B REPP R WEINER G GLENNIE M KALDEN JR VANDEWINKEL JGJ GRAMATZKI M

Citation: T. Valerius et al., EVALUATING B-CELL PANEL ANTIBODIES IN ADCC WITH G-CSF NEUTROPHILS AS EFFECTOR-CELLS, Tissue antigens, 48(4-II), 1996, pp. 111-111

Authors: VALERIUS T REPP R ELSASSER D WURFLEIN D WEINER GJ DEO Y KALDEN JR VANDEWINKEL JJG GLENNIE MJ GRAMATZKI M

Citation: T. Valerius et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH G-CSF, Blood, 86(10), 1995, pp. 2132-2132

Authors: VALERIUS T ELSASSER D REPP R STOCKMEYER B KALDEN JR GRAMATZKI M

Citation: T. Valerius et al., ANTIBODY-BASED THERAPEUTIC APPROACH TO B-CELL MALIGNANCIES WITH NEUTROPHILS AS POTENTIAL EFFECTOR-CELLS, Blood, 84(10), 1994, pp. 10000036-10000036